CHUNG-CHIH SHIHTZONG-SHIUN LEEFON-YIH TSUANGPEI-LIN LINYA-JUNG CHENGHSIAO-LIANG CHENGCHUN-YU WU2019-09-042019-09-042017-09-081949-2553https://www.scopus.com/inward/record.uri?eid=2-s2.0-85029800108&doi=10.18632%2foncotarget.18891&partnerID=40&md5=9316c00227bdd060210fc665171893ffhttps://scholars.lib.ntu.edu.tw/handle/123456789/417356Malignant primary brain tumors are one of the most aggressive cancers. Pretreatment serum nonneuronal biomarkers closely associated with postoperative outcomes are of high clinical relevance. The present study aimed to identify potential pretreatment serum biomarkers that may influence oncological outcomes in patients with primary brain tumors.enbrain tumor; glioma; lactate; prognostic factor; tumor markerBrain tumor; Glioma; Lactate; Prognostic factor; Tumor marker[SDGs]SDG3glial fibrillary acidic protein; lactate dehydrogenase; lactic acid; neuron specific enolase; neutrophil gelatinase associated lipocalin; protein S100B; tumor marker; adult; Article; brain surgery; brain tumor; cancer grading; cancer prognosis; cancer surgery; cancer survival; cohort analysis; controlled study; diagnostic test accuracy study; female; human; lactate blood level; major clinical study; male; overall survival; progression free survival; receiver operating characteristic; survival analysisjournal article10.18632/oncotarget.18891289690232-s2.0-85029800108WOS:000410284800074https://api.elsevier.com/content/abstract/scopus_id/85029800108